Osiris Therapeutics (OSIR) Posts Narrower than Expected Q1 Loss
Tweet
Share
E-mailGet Alerts OSIR Hot Sheet
Price: $18.99 --0%
Financial Fact:
Income before income taxes: -790K
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Income before income taxes: -790K
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Osiris Therapeutics (NASDAQ: OSIR) reported Q1 EPS of ($0.04), $0.05 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $3.45 million versus the consensus estimate of $3.45 million.
For earnings history and earnings-related data on Osiris Therapeutics (OSIR) click here.
For earnings history and earnings-related data on Osiris Therapeutics (OSIR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Algorhythm Holdings (RIME) Tops Q2 EPS by 54c
- Newton Golf Company (NWTG) Reports Q2 Loss of $0.49
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
